oasis-1 oral semaglutide 50 mg obesity nejm 2023 🥼🧪Slide Deck: Efficacy and safety of 25 in adults with overweight/obesity: the OASIS 4 RCT : r/Semaglutide Oral Semaglutide 25 mg Demonstrates

Improved Metabolism: These drugs may also contribute to better metabolic function by improving blood sugar control, which can help people with metabolic syndrome or insulin resistance

doi: 10.1016/j.intimp.2024.113173 155 NiuC.LvW.ZhuX.DongZ.YuanK.JinQ.et al

Jakobsson HE, Rodrguez-Pieiro AM, Schtte A, Ermund A, Boysen P, et al

Furthermore, it has been seen that a combination of CoQ10 and ALA is superior to monotherapy in treating oxidative nephrotoxicity induced by cisplatin [137]

[60] evaluated for potential differences in oxytocin receptor expression and distribution in the brain as a potential explanation for differences between juvenile versus adult rat behavior governing social interactions

Combined use may increase nausea, vomiting, hypoglycemia risk (especially on diabetes medications), and gastrointestinal discomfort due to overlapping effects on gastric emptying